QQ客服 官方微博 反馈留言

	PS01.80: Genome-Wide Screen of DNA Methylation Changes Reveals GABBR2 as a Novel Potential Target for EGFR 19 Deletion Adenocarcinoma with Erlotinib: Topic: Medical Oncology.
	Lu Shun; Niu Xiaomin; Liu Fatao; Zhou Yi; Zhou Zhen; Liu Yun; Chen Zhiwei
刊名	Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
	2016
卷号	11期号:11S
ISSN号	1556-1380
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3625292
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Lu Shun,Niu Xiaomin,Liu Fatao,et al. PS01.80: Genome-Wide Screen of DNA Methylation Changes Reveals GABBR2 as a Novel Potential Target for EGFR 19 Deletion Adenocarcinoma with Erlotinib: Topic: Medical Oncology.[J]. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,2016,11(11S).
APA	Lu Shun.,Niu Xiaomin.,Liu Fatao.,Zhou Yi.,Zhou Zhen.,...&Chen Zhiwei.(2016).PS01.80: Genome-Wide Screen of DNA Methylation Changes Reveals GABBR2 as a Novel Potential Target for EGFR 19 Deletion Adenocarcinoma with Erlotinib: Topic: Medical Oncology..Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,11(11S).
MLA	Lu Shun,et al."PS01.80: Genome-Wide Screen of DNA Methylation Changes Reveals GABBR2 as a Novel Potential Target for EGFR 19 Deletion Adenocarcinoma with Erlotinib: Topic: Medical Oncology.".Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 11.11S(2016).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。